Research programme: benzamide riboside analogues - PharmassetAlternative Names: Benzamide riboside analogues research programme - Pharmasset; PSI 5031
Latest Information Update: 20 Feb 2008
At a glance
- Originator Pharmasset
- Class Nucleosides
- Mechanism of Action Inosine monophosphate dehydrogenase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Colorectal cancer
Most Recent Events
- 03 Apr 2003 No development reported - Preclinical for Colorectal cancer in USA (unspecified route)
- 25 Jun 2001 New profile
- 25 Jun 2001 Preclinical development for Colorectal cancer in USA (Unknown route)